All articles
How Does Semaglutide Work?
Reading time:
7 min
Weight loss

Get expert guidance and a personalized care plan designed around you.
How Does Semaglutide Affect Blood Sugar, Metabolism, and Other Organ Systems?
Semaglutide improves blood sugar through multiple mechanisms. This is why semaglutide was originally developed as a treatment for type 2 diabetes before becoming widely used for weight management (2,3).
Semaglutide also improves overall metabolic health by:
Increasing insulin release when blood sugar rises
Reducing excess glucagon production (the hormone that releases sugar into your bloodstream)
Increasing beneficial metabolic hormones
Decreasing fat production by the liver (1)
These combined effects help stabilize blood sugar levels throughout your day.
Beyond blood sugar control, semaglutide appears to help several other aspects of health, including heart health. The SELECT trial showed that semaglutide 2.4 mg reduced the risk of cardiovascular death, nonfatal heart attack, and nonfatal stroke by 20% (9).
Other benefits include:
Decreased waist circumference
Lower blood pressure
Reduced LDL cholesterol and triglycerides
Improved HbA1c (9,10)
Interestingly, only about one-third of the cardiovascular benefit appears to be due to weight loss alone, suggesting direct protective effects on the heart and blood vessels (11). Researchers believe that semaglutide may also have direct effects on inflammation, blood vessels, and metabolic health.
How Is Semaglutide Different From Older Weight Loss Medications?
Semaglutide differs from many older weight loss medications in their mechanism of action.
Many older weight loss medications:
Only suppress appetite temporarily
Block calorie absorption
Stimulating the nervous system
Semaglutide is different because it targets hormonal pathways that naturally regulate eating behavior. Instead of focusing on one mechanism, semaglutide influences:
Hunger
Fullness
Food cravings
Blood sugar
Metabolism
FAQs
How long does semaglutide take to work?
Semaglutide begins working after the first dose. However, significant weight loss usually occurs over the course of several months.
Does semaglutide only work by slowing digestion?
Semaglutide’s long-term weight loss effects are primarily driven by changes in appetite regulation within the brain.
Why do I feel less hungry on semaglutide?
Semaglutide activates the glucagon-like peptide-1 receptors of the brain. This causes increased signals of fullness, helping people eat less.
Does semaglutide increase metabolism?
This medication works by reducing calorie intake and improving metabolic health. It does not primarily increase metabolic rate (aka calorie expenditure).
Check Your Eligibility
If you are taking semaglutide or considering it and are worried about the possibility of side effects, you are not alone. These concerns are extremely common, especially when starting a new medication or knowing someone who had side effects when taking a new medicine. A licensed provider can help you further evaluate your symptoms, review your labs, and determine whether this medication is right for you. Check your eligibility here.
References
Bansal MB, Patton H, Morgan TR, et al. Semaglutide Therapy for Metabolic Dysfunction-Associated Steatohepatitis: November 2025 Updates to AASLD Practice Guidance. Hepatology. 2025.
U.S. Food and Drug Administration. OZEMPIC (semaglutide) injection: Prescribing Information. Updated January 30, 2026.
Rosen CJ, Ingelfinger JR. GLP-1 Receptor Agonists. N Engl J Med. 2026.
Grunvald E, Shah R, Hernaez R, et al. AGA Clinical Practice Guideline on Pharmacological Interventions for Adults With Obesity. Gastroenterology. 2022.
Gabe MBN, Breitschaft A, Knop FK, et al. Effect of Oral Semaglutide on Energy Intake, Appetite, Control of Eating and Gastric Emptying in Adults With Obesity. Diabetes Obes Metab. 2024.
Friedrichsen M, Breitschaft A, Tadayon S, et al. Semaglutide 2.4 mg Once Weekly and Effects on Energy Intake and Gastric Emptying. Diabetes Obes Metab. 2021.
Bracchiglione J, Meza N, Franco JV, et al. Semaglutide for Adults Living With Obesity. Cochrane Database Syst Rev. 2025.
Aroda VR, Ahmann A, Cariou B, et al. SUSTAIN 1–7 Trials: Efficacy and Safety of Semaglutide. Diabetes Metab. 2019.
Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes (SELECT). N Engl J Med. 2023.
Kosiborod MN, Bhatta M, Davies M, et al. Semaglutide and Cardiometabolic Risk Factors. Diabetes Obes Metab. 2023.
Deanfield J, Lincoff AM, Kahn SE, et al. SELECT Trial Analysis of Cardiovascular Outcomes and Adiposity. Lancet. 2025.
Rubino DM, Greenway FL, Khalid U, et al. STEP 8 Trial: Semaglutide vs Liraglutide. JAMA. 2022.
Ghusn W, De la Rosa A, Sacoto D, et al. Weight Loss Outcomes With Semaglutide. JAMA Netw Open. 2022.
Disclaimer: This article is for educational purposes only and should not be considered medical advice. The information provided does not constitute recommendations for treatment. Always consult with your healthcare provider about your specific situation, symptoms, and treatment options.
Share this post
Weight loss
More articles













